Oleanolic acid is a selective farnesoid X receptor modulator

Phytotherapy Research

Volumn 24, Issue 3, 2010, Pages 369-373

  Liu, Wenming ^a   Wong, Chiwai ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Bile acids; FXR; Oleanolic acid

Indexed keywords

BILE SALT EXPORT PROTEIN; CARRIER PROTEIN; FARNESOID X RECEPTOR; OLEANOLIC ACID; ORGANIC SOLUTE TRANSPORTER BETA; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ARTICLE; BILE ACID METABOLISM; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; LIVER PROTECTION; PROTEIN EXPRESSION; RECEPTOR BINDING;

CELL LINE, TUMOR; CHENODEOXYCHOLIC ACID; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 3; OLEANOLIC ACID; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77349085586     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2948     Document Type: Article

References (22)

1. Braga F, Ayres-Saraiva D, Gattass CR, Capella MA. 2007. Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy. Cancer Lett 248: 147-152.
2. Chiang JY. 2004. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 40: 539-551.
3. Choi CY, You HJ, Jeong HG. 2001. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages. Biochem Biophys Res Commun 288: 49-55.
4. Cui J, Huang L, Zhao A et al. 2003. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem 278: 10214-10220.
5. Forman BM. 1995. Identification of a nuclear receptor that is activated by faneesol metabolites. Cell 81: 687-693.
6. Giner-Larza EM, Manez S, Recio MC et al. 2001. Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J Pharmacol 428: 137-143.
7. Hofmann AF. 1999. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159: 2647-2658.
8. Jeong HG. 1999. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 105: 215-222.
9. Liu J. 2005. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol 100: 92-94.
10. Liu J, Wu Q, Lu YF, Pi J. 2008. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. Biochem Pharmacol 76: 922-928.
11. Lu TT, Makishima M, Repa JJ et al. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6: 507-515.
12. Martinez-Gonzalez J, Rodriguez-Rodriguez R, Gonzalez-Diez M et al. 2008. Oleanolic acid induces prostacyclin release in human vascular smooth muscle cells through a cyclooxygenase-2-dependent mechanism. J Nutr 138: 443-448.
13. Parks DJ, Blanchard SG, Bledsoe RK et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284: 1365-1368.
14. Russell DW. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72: 137-174.
15. Sanyal S, Kim JY, Kim HJ et al. 2002. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. J Biol Chem 277: 1739-1748.
16. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. 2000. Targeted disruption of the nuclear receptor FXR/ BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744.
17. Tang XH, Gao J, Fang F et al. 2005. Hepatoprotection of oleanolic acid is related to its inhibition on mitochondrial permeability transition. Am J Chin Med 33: 627-637.
18. Teodoro T, Zhang L, Alexander T, Yue J, Vranic M, Volchuk A. 2008. Oleanolic acid enhances insulin secretion in pancreatic beta-cells. FEBS Lett 582: 1375-1380.
19. Wang B, Jiang ZH. 1992. Studies on oleanolic acid. Chin Pharm J 27: 393-397.
20. Wang YD, Chen WD, Huang W. 2008. FXR, a target for different diseases. Histol Histopathol 23: 621-627.
21. Warnmark A, Treuter E, Wright AP, Gustafsson JA. 2003. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 17: 1901-1909.
22. Zollner G, Marschall HU, Wagner M, Trauner M. 2006. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3: 231-251.